Skip to main content
Clinical Trials/NCT06452472
NCT06452472
Completed
Not Applicable

Observational Study of People with Complete Hand Amputation Using a Multi-grip Myoelectric Prosthesis a Following Using a Standard Myoelectric Prosthesis

Össur Ehf1 site in 1 country25 target enrollmentJanuary 22, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Amputation of Upper Limb
Sponsor
Össur Ehf
Enrollment
25
Locations
1
Primary Endpoint
Change in daily living with his/her prosthesis
Status
Completed
Last Updated
last year

Overview

Brief Summary

Cases of unilateral or bilateral upper limb amputation result in functional and aesthetic disability and a marked deterioration in quality of life. Amputees may use no prostheses, or use a combination of cosmetic prostheses, body-powered prostheses, or myoelectric prostheses (MHP). Among MHP, there are standard MHPs with a single degree of freedom (DOF) and one grip type, and multi-grip myoelectric hand (MG-MHP) with multiple DOF.

Amputees who do not use a prosthesis or a cosmetic prosthesis appear to have more difficulties in their daily activities and a greater disability than those who use body powered or myoelectric prostheses. While theoretically a MG-MHP offers the potential for subjects to perform more natural movements than a standard MHP, clinical evidence substantiating the advantages of MG-MHP over standard MHP in daily life remains inconclusive.

It remains essential to compare the advantages of MG-MHPs versus standard MHPs regarding functionality in daily life, quality of life and overall satisfaction among subjects who agree to transition from their standard MHP to a MG-MHP. The primary objective of this study was to assess upper limb function (specifically, the upper limb function component of the Orthotics and Prosthetics Users' Survey (OPUS) questionnaire) provided by a specific MG-MHP, i-Limb®, compared to a standard MHP in subjects with complete hand amputation.

The subjects participating in the study were patients equipped with MHP, coming to the center for a MG-MHPs hand test. If the prescription for the MG-MHPs hand was validated, the patient was then followed in the study for 8 to 10 weeks.

Registry
clinicaltrials.gov
Start Date
January 22, 2019
End Date
December 19, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Össur Ehf
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient aged over 18 years old
  • Patient with a unilateral acquired or congenital complete amputation
  • Patient using a standard myoelectric hand prosthesis for at least 4 weeks
  • Patient who has an indication of a Multi-Grip Myoelectric Hand Prosthesis , according to a multidisciplinary team

Exclusion Criteria

  • Pregnant women
  • Patient under guardianship
  • Patient with multiple amputations

Outcomes

Primary Outcomes

Change in daily living with his/her prosthesis

Time Frame: at 8-10 weeks

Assessed with upper limb function component of the Orthotics and prosthetics Users 'Survey (OPUS) which includes 23 questions and explores the ease with which the subject performs 23 activities of daily living with his/her prosthesis. The questions are rated from 4 very easy; 3 Easy 2 Slightly difficult; 1 Very difficult; 0 Cannot perform activity. The total score ranges from a minimum of 0 to a maximum of 92. A higher score correlates with an enhanced perception of functional

Secondary Outcomes

  • Change in satisfaction of the patient assessed with ESAT(at 8-10 weeks)
  • Change in the quality-of-life with his/her prosthesis(at 8-10 weeks)
  • Change is the satisfaction of the patient with his/her prosthesis(at 8-10 weeks)
  • Change is the satisfaction of the patient to the services provided assessed with OPUS(at 8-10 weeks)
  • Change in the overall satisfaction of the patient on a Likert scale(at 8-10 weeks)
  • Change in the Quick-DASH functional scale(at 8-10 weeks)

Study Sites (1)

Loading locations...

Similar Trials